Yihong Sun
About
Yihong Sun is a scholar working on Pulmonary and Respiratory Medicine, Gastroenterology and Oncology.
According to data from OpenAlex, Yihong Sun has authored 142 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Pulmonary and Respiratory Medicine, 43 papers in Gastroenterology and 42 papers in Oncology. Recurrent topics in Yihong Sun's work include Gastric Cancer Management and Outcomes (61 papers), Gastrointestinal Tumor Research and Treatment (43 papers) and Metastasis and carcinoma case studies (39 papers). Yihong Sun is often cited by papers focused on Gastric Cancer Management and Outcomes (61 papers), Gastrointestinal Tumor Research and Treatment (43 papers) and Metastasis and carcinoma case studies (39 papers). Yihong Sun collaborates with scholars based in China, United States and Japan. Yihong Sun's co-authors include Xuefei Wang, Jing Qin, Zhenbin Shen, Jiejie Xu, Xinyu Qin, Zhaoqing Tang, Heng Zhang, Hongyong He, Chao Lin and Hao Liu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.
In The Last Decade
Yihong Sun
135 papers receiving 3.3k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Yihong Sun China | 32 | 1.3k | 1.2k | 1.2k | 776 | 620 | 142 | 3.4k | ||
| Masahide Ikeguchi Japan | 40 | 1.4k 1.1× | 1.7k 1.4× | 1.8k 1.6× | 677 0.9× | 470 0.8× | 198 | 4.6k | ||
| Shunchang Jiao China | 30 | 1.1k 0.9× | 1.9k 1.6× | 977 0.8× | 618 0.8× | 655 1.1× | 144 | 3.4k | ||
| Tetsuya Toge Japan | 29 | 1.2k 1.0× | 1.2k 1.0× | 638 0.6× | 433 0.6× | 457 0.7× | 179 | 2.9k | ||
| Chunhua Yu United States | 24 | 1.3k 1.0× | 319 0.3× | 1.3k 1.1× | 444 0.6× | 812 1.3× | 45 | 3.1k | ||
| Keishi Yamashita Japan | 44 | 3.4k 2.6× | 2.2k 1.9× | 2.0k 1.7× | 527 0.7× | 1.1k 1.7× | 265 | 6.8k | ||
| Taizo Shiraishi Japan | 35 | 1.5k 1.2× | 904 0.8× | 1.4k 1.2× | 244 0.3× | 579 0.9× | 145 | 3.7k | ||
| Leizhen Zheng China | 19 | 717 0.6× | 1.2k 1.0× | 1.2k 1.0× | 141 0.2× | 331 0.5× | 40 | 2.3k | ||
| Tomoya Yokota Japan | 31 | 799 0.6× | 1.4k 1.2× | 1.4k 1.2× | 164 0.2× | 325 0.5× | 186 | 3.3k | ||
| Michael K. Gibson United States | 33 | 2.0k 1.5× | 2.7k 2.3× | 2.6k 2.3× | 425 0.5× | 901 1.5× | 155 | 6.5k | ||
| Hirokazu Taniguchi Japan | 30 | 1.4k 1.1× | 1.1k 0.9× | 553 0.5× | 238 0.3× | 431 0.7× | 140 | 3.4k |
Countries citing papers authored by Yihong Sun
Since
Specialization
Citations
This map shows the geographic impact of Yihong Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yihong Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yihong Sun more than expected).
Fields of papers citing papers by Yihong Sun
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Yihong Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yihong Sun. The network helps show where Yihong Sun may publish in the future.
Co-authorship network of co-authors of Yihong Sun
This figure shows the co-authorship network connecting the top 25 collaborators of Yihong Sun. A scholar is included among the top collaborators of Yihong Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yihong Sun. Yihong Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Zhou, Aiping, Zheng Li, Yihong Sun, et al.. (2025). LBA84 Efficacy and safety of GFH375 monotherapy in previously treated advanced KRAS G12D-mutant pancreatic ductal adenocarcinoma (PDAC). Annals of Oncology. 36. S1626–S1626.
2.
Yang, Jing, Zhihui Li, Yihong Sun, et al.. (2025). Tailoring the low-temperature denitrification window of MnCrNi catalysts through Ni source engineering: The effect of nickel precursors on activity. Applied Surface Science. 712. 164229–164229.
3.
Wang, Xin, Yuan Gu, Zhenxing Zhong, et al.. (2025). Proteasome stress activates YAP/TAZ through the RAP2–MAP4Ks–LATS1/2 pathway and its therapeutic implications in solid tumors. Proceedings of the National Academy of Sciences. 122(51). e2517376122–e2517376122.
4.
Zhang, Anchao, Yihong Sun, Hua Wang, et al.. (2024). Fabrication of recoverable Bi2O2S/Bi5O7I/ZA hydrogel beads for enhanced photocatalytic Hg0 removal in the presence of H2O2. Separation and Purification Technology. 359. 130597–130597.
5.
Min, Lingqiang, Bo Zhou, Peng Zhou, et al.. (2024). Transarterial Infusion Chemotherapy and Embolization for Patients With Unresectable Advanced Cancer of Stomach or Gastroesophageal Junction: A Retrospective Study. Cancer Medicine. 13(21). e70396–e70396.
6.
Zhao, Junjie, Zhaoming Wang, Chenyu Tian, et al.. (2023). Single-cell RNA sequencing reveals the lineage of malignant epithelial cells and upregulation of TAGLN2 promotes peritoneal metastasis in gastric cancer. Clinical & Translational Oncology. 25(12). 3405–3419.
7.
Zhang, Xianghua, Liang Han, Yingwei Xue, et al.. (2023). LBA78 Overall survival of perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy: An updated analysis of RESOLVE trial. Annals of Oncology. 34. S1318–S1319.
8.
Wu, Yingying, Junjie Zhao, Zhaoming Wang, et al.. (2023). Association of systemic inflammatory markers and tertiary lymphoid structure with pathological complete response in gastric cancer patients receiving preoperative treatment: a retrospective cohort study. International Journal of Surgery. 109(12). 4151–4161.
9.
Tang, Zhaoqing, Yan Wang, Yiyi Yu, et al.. (2022). Neoadjuvant apatinib combined with oxaliplatin and capecitabine in patients with locally advanced adenocarcinoma of stomach or gastroesophageal junction: a single-arm, open-label, phase 2 trial. BMC Medicine. 20(1). 107–107.
10.
Li, Haojie, Junjie Zhao, Jie Sun, et al.. (2021). Demethylation of the SFRP4 Promoter Drives Gastric Cancer Progression via the Wnt Pathway. Molecular Cancer Research. 19(9). 1454–1464.
11.
Sun, Xiaomao, Wei Yuan, Min Fu, et al.. (2020). [Clinicopathological features and prognosis of 59 patients with platelet-derived growth factor α-mutant gastrointestinal stromal tumor].. PubMed. 23(9). 880–887.
12.
Wang, Xuefei, Junjie Zhao, Mark Fairweather, et al.. (2019). Optimal treatment for elderly patients with resectable proximal gastric carcinoma: a real world study based on National Cancer Database. BMC Cancer. 19(1). 1079–1079.
13.
Xu, Chen, Yalan Liu, Dongxian Jiang, et al.. (2017). HER 2 assessment in locally advanced gastric cancer: comparing the results obtained with the use of two primary tumour blocks versus those obtained with the use of all primary tumour blocks. Histopathology. 71(4). 570–579.
14.
Tang, Zhaoqing, Ji Ma, Wei Zhang, et al.. (2016). The Role of Prion Protein Expression in Predicting Gastric Cancer Prognosis. Journal of Cancer. 7(8). 984–990.
15.
Ling, Chen, Lingqiang Min, Xuefei Wang, et al.. (2015). Loss of RACK1 Promotes Metastasis of Gastric Cancer by Inducing a miR-302c/IL8 Signaling Loop. Cancer Research. 75(18). 3832–3841.
16.
Ge, Xiaowen, Hai Wang, Haiying Zeng, et al.. (2015). Clinical significance of assessing Her2/neu expression in gastric cancer with dual tumor tissue paraffin blocks. Human Pathology. 46(6). 850–857.
17.
Sun, Yihong & Xuefei Wang. (2014). Minimally invasive surgery for the treatment of adenocarcinoma of the esophagogastric junction. Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 13(2). 89–91.
18.
Wang, Yan, Yiyi Yu, Wěi Li, et al.. (2014). A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis. Cancer Chemotherapy and Pharmacology. 73(6). 1155–1161.
19.
Wang, Xuefei, Hongyong He, Heng Zhang, et al.. (2012). Clinical and prognostic implications of β1, 6‐N‐acetylglucosaminyltransferase V in patients with gastric cancer. Cancer Science. 104(2). 185–193.
20.
Li, Wěi, Tianshu Liu, Yihong Sun, et al.. (2011). [Adjuvant chemotherapy for gastric cancer: more drugs do not mean better efficacy].. PubMed. 14(6). 432–5.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Masahide Ikeguchi Breakdown of academic impact, for papers by Shunchang Jiao Breakdown of academic impact, for papers by Tetsuya Toge Breakdown of academic impact, for papers by Chunhua Yu Breakdown of academic impact, for papers by Keishi Yamashita Breakdown of academic impact, for papers by Taizo Shiraishi Breakdown of academic impact, for papers by Leizhen Zheng Breakdown of academic impact, for papers by Tomoya Yokota Breakdown of academic impact, for papers by Michael K. Gibson Breakdown of academic impact, for papers by Hirokazu Taniguchi